Learn

Saturday, 21 November

FMGE · blueprint and recall

FMGE Antipsychotics

Candidates recalled antipsychotics from 6 of the 19 FMGE sessions in this collection, including 4 of the 11 well-covered ones. It first appears in FMGE Jun 2009 and last in FMGE Jan 2025. 3 of its 4 recalled concepts came as clinical vignettes.

Concepts in recalled topics
4
unofficial
Sessions seen in
6
Well-covered sessions
4
with this topic recorded
Image-linked concepts
0

Recurrence in this collection

Each recalled session counts once for this topic, even if it contains several related concepts.

Seen in 6 of the 19 sessions with recall; 4 of the 11 well-covered sessions.

First seen: FMGE Jun 2009. Last seen: FMGE Jan 2025.

First and last seen refer to this recall collection only. Thin coverage limits what absence can tell you. Read the method.

Question styles and image links

Question styles in the recall

vignette
3 concepts · 75.0%
one-liner
1 concepts · 25.0%

Within this topic

Finer labels from the unofficial recall, grouped under Lumi's outline topic.

Subtopics represented

  • Atypical antipsychotics
  • Neuroleptic malignant syndrome
  • Antipsychotic adverse effects

Image types recorded

No concepts recorded in this category.

Image-type percentages use all 4 concepts in this topic as the denominator. The labels describe images in recall; no images are reproduced.

Related topics in this chapter

  • Central Nervous System

    Antiepileptics

    Seen in 10 of the 19 sessions with recall; 7 of the 11 well-covered sessions.

    First seen: FMGE Jun 2009. Last seen: FMGE Jan 2025.

    Styles: one-liner (6) · vignette (2) · image + vignette (1).

  • Central Nervous System

    Opioids

    Seen in 3 of the 19 sessions with recall; 3 of the 11 well-covered sessions.

    First seen: FMGE Dec 2019. Last seen: FMGE Jul 2025.

    Styles: one-liner (2).

  • Central Nervous System

    Antiparkinsonian drugs

    Seen in 2 of the 19 sessions with recall; 2 of the 11 well-covered sessions.

    First seen: FMGE Aug 2020. Last seen: FMGE Jun 2022.

    Styles: one-liner (1) · vignette (1).

  • Central Nervous System

    Antidepressants

    Seen in 2 of the 19 sessions with recall; 2 of the 11 well-covered sessions.

    First seen: FMGE Jun 2019. Last seen: FMGE Jun 2022.

    Styles: one-liner (1).

  • Central Nervous System

    General and local anaesthetics

    Seen in 2 of the 19 sessions with recall; 1 of the 11 well-covered sessions.

    First seen: FMGE Dec 2011. Last seen: FMGE Dec 2018.

    Styles: one-liner (2).

  • Central Nervous System

    Sedative-hypnotics

    Seen in 2 of the 19 sessions with recall; 1 of the 11 well-covered sessions.

    First seen: FMGE Jun 2019. Last seen: FMGE Jul 2023.

    Styles: one-liner (1).

All of Central Nervous System, including unseen topics →